Evidence map›Paper›PMID 22211660›Full record

ArticleCurrent HIV research2011

Control of HIV latency by epigenetic and non-epigenetic mechanisms.

Uri Mbonye, Jonathan Karn

Open access · bronzeAbstract read
In one paragraph

Article in Current HIV research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 99 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. A functional screen identifies transcriptional networks that regulate HIV-1 and HIV-2.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. The state of latency in microbial pathogenesis.The Journal of clinical investigation · 2020
    Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution.

Uri MbonyeDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Jonathan Karn
Case Comprehensive Cancer Center

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Using NK Cells to eliminate the latent HIV reservoirU19AI096113 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2011 to 2015
$39.5M
Manipulating Epigenetic Control Mechanisms to Control HIV TranscriptionDP1DA028869 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2009 to 2013
$3.9M
HIV Latency, Epigenetics, and TherapeuticsR01DA030156 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2010 to 2014
$3.0M
Molecular mechanisms regulating HIV entry and exit from latencyR01AI067093 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2007 to 2011
$1.9M
NIAID NIH HHS 1U19AI096113NIAID NIH HHS P30 AI036219NIAID NIH HHS R01 AI067093NIAID NIH HHS U19 AI096113NIDA NIH HHS 1 R01 DA030156NIDA NIH HHS DP1 DA028869NIDA NIH HHS R01 DA030156
6 · The paper itself

Abstract

Intensive antiretroviral therapy successfully suppresses viral replication but is unable to eradicate the virus. HIV persists in a small number of resting memory T cells where HIV has been transcriptionally silenced. This review will focus on recent insights into the HIV transcriptional control mechanisms that provide the biochemical basis for understanding latency. There are no specific repressors of HIV transcription encoded by the virus, instead latency arises when the regulatory feedback mechanism driven by HIV Tat expression is disrupted. Small changes in transcriptional initiation, induced by epigenetic silencing, lead to profound restrictions in Tat levels and force the entry of proviruses into latency. In resting memory T cells, which carry the bulk of the latent viral pool, additional restrictions, especially the limiting cellular levels of the essential Tat cofactor P-TEFb and the transcription initiation factors NF-κB and NFAT ensure that the provirus remains silenced unless the host cell is activated. The detailed understanding of HIV transcription is providing a framework for devising new therapeutic strategies designed to purge the latent viral pool. Importantly, the recognition that there are multiple restrictions imposed on latent proviruses suggest that proviral reactivation will not be achieved when only a single reactivation step is targeted and that any optimal activation strategy will require both removal of epigenetic blocks and the activation of P-TEFb.

Indexed as

Antiretroviral Therapy, Highly ActiveDisease ReservoirsEpigenesis, GeneticHIVHIV InfectionsHumanstat Gene Products, Human Immunodeficiency VirusT-LymphocytesTranscription, GeneticVirus Latencytat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID22211660
PMCPMC3319922
OpenAlexW2069932442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.